Day One Biopharmaceuticals, Inc. ($DAWN)
Filing Information
| Accession Number | 0001734755-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,978
Total Value
$31,647.26
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Head of Research and Dev. | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 7,125 | โ | โ | 7,125 | Direct | โ | View Details | |
Head of Research and Dev. | Common Stock | โ | Feb 17, 2026 | Sale | 2,728 | $11.60 | $31,647.26 | 4,397 | Direct | โ | View Details | |
Head of Research and Dev. | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 7,125 | $0.00 | $0.00 | 106,875 | Direct | โ | View Details |